Statement from FDA on continuing efforts to maintain its strong oversight of generic drugs
date:Feb 25, 2019
Today, we want to explain some of the fundamental steps we take to protect the quality and effectiveness of generic medicines that consumers and patients rely on every day and address what we believe are shortcomings in the analyses that have been performed by some news outlets. We recognize that our statement, in part directly responding to a news report, is not customary; we nonetheless feel obligated to provide a substantive response given the public health issues at stake.

Consumers must ha
3/35 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/16 12:01